Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

Patients with de novo metastatic nasopharyngeal carcinoma were historically deemed incurable and treated with palliative intent. Emergence of potent systemic therapy in combination with local treatment for both locoregional and metastatic diseases has enabled long-term survival in some patients. This international guid...

Qiao-Juan Guo, Qin Liu, P. Bossi et al. · 0 citations
Open access Sep 2026

A phase I, dose-escalation study of weekly vinflunine in patients with advanced solid tumours

Introduction: We aimed to investigate the dose-limiting toxicity and to determine the maximum tolerated dose of vinflunine (Javlor®, Pierre Fabre, Castres, France) given by weekly intravenous infusions for at least four consecutive weeks in patients with advanced solid tumours and to explore the pharmacokinetic profile...

P. Szturz, Jan B. Vermorken, R. Stupp et al. · 0 citations
Open access Sep 2026

Personalized neoantigen vaccine platform and longitudinal tracking of vaccine-related clonotypes enable the identification of tumor-specific TCRs

This proof-of-concept study demonstrates that personalized neoantigen vaccination can induce durable and diverse tumor-specific T-cell responses in ovarian cancer and establishes a framework for using vaccination as an in vivo platform to identify clinically relevant tumor-specific TCRs for future cellular therapies.

Laurent Beziaud, P. Szturz, A. Sarivalasis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.